Choroidal Neovascularization, Age-related Macular Degeneration

1 clinical trials · Condition

Record	Firm	Date
An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO (NCT00379795)	Genentech, Inc.	2005-04-01

Every clearance here is in the API, with alerts when new ones post.